MilliporeSigma receives the industry's first EXCiPACT certification for cell culture media manufacturing

Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics

Albertsons Companies pharmacies now offer COVID and flu vaccines to help protect communities this respiratory virus season

OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award

Gilead’s Livdelzi (Seladelpar) receives FDA accelerated approval for primary biliary cholangitis

ProJenX announces the formation of its Clinical Advisory Board

Citius Pharmaceuticals' LYMPHIR™ wins FDA approval for relapsed/refractory cutaneous T-cell lymphoma

NewAmsterdam Pharma announces positive topline data from the Phase 3 BROOKLYN trial of Obicetrapib in heterozygous familial hypercholesterolemia patients

Cygnus Technologies and TriLink BioTechnologies® collaborate to launch AccuRes™ Host Cell DNA Quantification Kits

Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules.

Updated flu and COVID-19 vaccinations are now available at CVS Pharmacy® and MinuteClinic

$FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma$

FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma

Featured Press Releases

Mercury Bio's new project includes Los Alamos and the National Center for Genome Resources.

Cure51 selects 10x Genomics Visium HD to drive its new drug discovery initiative

31 Oct 2024

French TechBio startup Cure51 and 10x Genomics, Inc., a leader in single cell and spatial biology,...

Promega introduces the GloMax® Galaxy Bioluminescence Imager to illuminate protein dynamics in real time

Cognito Therapeutics Presents Spectris™ Data on Brain Structural Maintenance in Alzheimer’s at AD/PD™ 2025

Cosette Pharmaceuticals names Vincent Colicchio as Senior Vice President of Operations

Sun Pharma Announces the Launch of LEQSELVI™ (deuruxolitinib) in the United States for Treating Severe Alopecia Areata

Niagen Bioscience's Pharmaceutical-Grade Niagen™ IV and Injections Are Now Available at Over 50 iCRYO Clinics and More Than 900 Clinics Nationwide

By Niagen Bioscience, Inc
Niagen Bioscience, Inc
01 Oct 2025

Novartis Receives FDA Approval for Rhapsido® (remibrutinib), the First Oral, Targeted BTKi Treatment for Chronic Spontaneous Urticaria (CSU

By Novartis Pharmaceuticals Corporation
Novartis Pharmaceuticals Corporation
01 Oct 2025

CollPlant Biotechnologies Announces Positive Non-Clinical Study Results for Its Photocurable Regenerative Dermal and Soft Tissue Filler

By CollPlant
CollPlant
30 Sep 2025

Corstasis Therapeutics and U.S. Heart and Vascular® will collaborate to improve heart failure care with ENBUMYST™ (Bumetanide Nasal Spray

By Corstasis Therapeutics Inc.
Corstasis Therapeutics Inc.
29 Sep 2025

Leqembi® has received approval for intravenous maintenance treatment in China

By BioArctic AB
BioArctic AB
29 Sep 2025

At the Heart Failure Society of America, Bayer will showcase new data for KERENDIA® (finerenone)

By Bayer
Bayer
25 Sep 2025

Pharmaceutical

2nd International Conference on Stem Cells and Regenerative Medicine 2025

10 Nov 2025 10:00 am - 11 Nov 2025 5:30 pm

USA
Pharmaceutical

2nd International Conference on Immunology & Vaccination 2025

10 Nov 2025 10:00 am - 12 Nov 2025 5:30 pm

Paris

Most Popular

Genmab: Epcoritamab combo shows high response in R/R DLBCL patients eligible for ASCT

By Genmab

Jun 13
Avenacy Enters U.S. Market with Launch of Doxycycline for Injection, USP

By Avenacy

May 27
enGene’s Detalimogene Receives RMAT Designation from the FDA, Opening the Path for Expedited Review in High-Risk, Non-Muscle Invasive Bladder Cancer

By enGene Holdings Inc.

Jun 25

October 2025

M	T	W	T	F	S	S
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

Search your requirement

Social media

MilliporeSigma receives the industry's first EXCiPACT certification for cell culture media manufacturing

Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics

Albertsons Companies pharmacies now offer COVID and flu vaccines to help protect communities this respiratory virus season

OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award

Gilead’s Livdelzi (Seladelpar) receives FDA accelerated approval for primary biliary cholangitis

ProJenX announces the formation of its Clinical Advisory Board

Citius Pharmaceuticals' LYMPHIR™ wins FDA approval for relapsed/refractory cutaneous T-cell lymphoma

NewAmsterdam Pharma announces positive topline data from the Phase 3 BROOKLYN trial of Obicetrapib in heterozygous familial hypercholesterolemia patients

Cygnus Technologies and TriLink BioTechnologies® collaborate to launch AccuRes™ Host Cell DNA Quantification Kits

Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules.

Updated flu and COVID-19 vaccinations are now available at CVS Pharmacy® and MinuteClinic

FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma

Featured Press Releases

Mercury Bio's new project includes Los Alamos and the National Center for Genome Resources.

Cure51 selects 10x Genomics Visium HD to drive its new drug discovery initiative

Promega introduces the GloMax® Galaxy Bioluminescence Imager to illuminate protein dynamics in real time

Cognito Therapeutics Presents Spectris™ Data on Brain Structural Maintenance in Alzheimer’s at AD/PD™ 2025

Cosette Pharmaceuticals names Vincent Colicchio as Senior Vice President of Operations

Sun Pharma Announces the Launch of LEQSELVI™ (deuruxolitinib) in the United States for Treating Severe Alopecia Areata

Niagen Bioscience's Pharmaceutical-Grade Niagen™ IV and Injections Are Now Available at Over 50 iCRYO Clinics and More Than 900 Clinics Nationwide

Novartis Receives FDA Approval for Rhapsido® (remibrutinib), the First Oral, Targeted BTKi Treatment for Chronic Spontaneous Urticaria (CSU

CollPlant Biotechnologies Announces Positive Non-Clinical Study Results for Its Photocurable Regenerative Dermal and Soft Tissue Filler

Corstasis Therapeutics and U.S. Heart and Vascular® will collaborate to improve heart failure care with ENBUMYST™ (Bumetanide Nasal Spray

Leqembi® has received approval for intravenous maintenance treatment in China

At the Heart Failure Society of America, Bayer will showcase new data for KERENDIA® (finerenone)

Most Popular

Genmab: Epcoritamab combo shows high response in R/R DLBCL patients eligible for ASCT

Avenacy Enters U.S. Market with Launch of Doxycycline for Injection, USP

enGene’s Detalimogene Receives RMAT Designation from the FDA, Opening the Path for Expedited Review in High-Risk, Non-Muscle Invasive Bladder Cancer

User Area

Discover

Engage with Us

Search your requirement

Social media

Featured Press Releases

Most Popular

User Area

Discover

Engage with Us

Subscribe for e-Newsletter Monthly